Barcena, Rafael

Publishing since 1997 (Senior)

Has published 70 publications in 13 years

Number of publications published per year by Barcena, Rafael. (Source : PubMed)

Distribution of publications types for Barcena, Rafael. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Moreno A, Pérez-Elías MJ, Casado JL, Fortún J, Bárcena R, Quereda C, Del Campo S, Gutiérrez C, Pastor O, Nuño J, Fernandez A, Moreno S. Raltegravir-based highly active antiretroviral therapy has beneficial effects on the renal function of human immunodeficiency virus-infected patients after solid organ transplantation.  Liver Transpl.  2009  
•  Bárcena R, Moreno A, Foruny JR, Blázquez J, Graus J, Riesco JM, Blesa C, García-Hoz F, Sánchez J, Gil-Grande L, Nuño J, Fortún J, Rodriguez-Sagrado MA, Moreno A. Partial splenic embolization and peg-IFN plus RBV in liver transplanted patients with hepatitis C recurrence: safety, efficacy and long-term outcome.  Clin Transplant  2009  
•  Rivero M, Crespo L, Arranz G, Ledo A, Teruel C, Graus J, Bárcena R. [Bronchiolitis obliterans with organizing pneumonia associated with sirolimus in a patient after liver transplantation]  Rev Esp Enferm Dig  2009;101;8  
•  Redondo I, Otón E, Bárcena R, Del Campo S, Rodriguez-Gandía M, Cuervas-Mons V. Hepatitis C virus sensitivity to combined antiviral therapy in liver transplant versus immunocompetent patients.  Transplant. Proc.  2009;41;6  
•  Nashan B, Saliba F, Durand F, Barcéna R, Herrero JI, Mentha G, Neuhaus P, Bowles M, Patch D, Bernardos A, Klempnauer J, Bouw R, Ives J, Mamelok R, McKay D, Truman M, Marotta P. Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients.  Liver Transpl.  2009;15;2  
•  Fortún J, Martín-Dávila P, Alvarez ME, Norman F, Sánchez-Sousa A, Gajate L, Bárcena R, Nuño SJ, Moreno S. False-positive results of Aspergillus galactomannan antigenemia in liver transplant recipients.  Transplantation  2009;87;2  
•  Moreno A, Bárcena R, García-Gonzalez M, García-Hoz F, Quereda C, Casado JL, Pérez-Elías MJ, Fortún J, Nuño J, Arranz I, Moreno S. Severe sirolimus-related inflammatory state anemia in an HIV+ liver transplant patient with calcineurin inhibitor renal insufficiency: a case report.  Transplant. Proc.  2008;40;10  
•  Romero-Gómez M, Fernández-Rodríguez CM, Andrade RJ, Diago M, Alonso S, Planas R, Solá R, Pons JA, Salmerón J, Barcena R, Perez R, Carmona I, Durán S. Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C.  J. Hepatol.  2008;48;5  
•  Moreno A, Bárcena R, Quereda C, Casado JL, Pérez-Elías MJ, Fortún J, Nuño J, Arranz I, Moreno S. Safe use of raltegravir and sirolimus in an HIV-infected patient with renal impairment after orthotopic liver transplantation.  AIDS  2008;22;4  
•  Oton E, Barcena R. Severe hepatitis C recurrence: is it a negative predictive factor for sustained response to treatment?  Gastroenterology  2008;134;1  

[ See timeline ] [ See all publications ]